Read More Pharma Industry News Cerevel launches phase 3 Parkinson’s disease clinical trials for tavapadon Parkinson’s disease clinical trials : Cerevel Therapeutics, a US biopharma company, has initiated a phase 3 clinical trial… bypharmanewsdailyJanuary 15, 2020
